Outsource Research
There are many good reasons for your organisation to completely or partially outsource research on a contract basis, i.e., contract research. Collaborating with the Amsterdam research landscape not only saves time and reduces costs, your company will also benefit enormously by gaining access to specialised knowledge or expertise, and cutting-edge facilities. For instance:
- laboratory experiments
- production of (small quantities) of specific compounds or materials (contract manufacturing)
- access to high-tech facilities such as lab facilities, advanced equipment, databases or rare collections and archives
- further development and/or validation of methodologies
Continue reading after the photo.
Good agreements and legal contracts
Successful collaborations start with good agreements. In contract research and contract manufacturing, you determine together with the researcher what is to be expected in terms of output (data, materials, inventories, reports etc.) and standards (quality standards etc.). Besides discussing which joint efforts are needed to deliver the required outcomes, financial and legal matters have to be tackled, such as fees, intellectual property rights and ownership on application.
IXA’s legal experts and business developers provide support and advice in the negotiations and in drafting public-private partnership contracts. These contracts will be fine-tuned to the particular nature of the activities and the needs and interests of the parties involved.
UvA spin-off Panel BV receives PoC funding from Innovatiefonds Noord-Holland (IFNH)
Panel B.V., a spin-off from the University of Amsterdam, has received a loan from the Innovatiefonds Noord-Holland. This loan will enable Panel to continue building its innovative tool for inclusive participation processes. The unique method was designed by sociologists Gerben Moerman and Christiaan Bröer of the UvA Faculty of Social and Behavioural Sciences. The method […]
News
Phlox Therapeutics raises additional seed funding for RNA therapies
Phlox, a private biotechnology spin-off from Amsterdam UMC and specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies, has secured additional seed funding to advance Phlox’s lead program aimed at rare genetic laminopathies.
News
Two VU start-ups in Techleap’s Pole Position programme
Photosynthetic & Veridis, two VU start-ups, are part of the Pole Position Programme #4 by Techleap. Through the programme, like-minded industry experts who will guide the founders of Photosynthetic & Veridis on their journey towards becoming global leaders and take Pole Position. Techleap is a government funded organization to connect and empower startups to grow and sustain a productive tech community.
News